1289 Aufrufe 1289 0 Kommentare 0 Kommentare

    NuGen Receives Order for Repeat Demand in Mexico - Seite 2

    About NuGen

    NuGen is a leading developer of needle-free devices to administer therapeutics subcutaneously.

    The Company is marketing and selling its next-generation InsuJet™ needle-free injection system designed to improve the lives of millions of diabetics.

    InsuJet™ is approved for sale in 42 countries around the world.

    For further information, please visit:

    Websites: www.insujet.com, www.nugenmd.com and www.solm.com/insujet/

    Instagram: @NuGenMD

    Twitter: @NuGenMD

    LinkedIn: https://www.linkedin.com/company/nugenmd/
    and www.linkedin.com/company/sol-millennium-medical-group/

    For further information, please contact:

    Tony Di Benedetto
    Executive Chairman
    (416) 791-9399
    tony@nugenmd.com

    Ian Heynen
    CEO
    (416) 560-1019
    ian@nugenmd.com

    To arrange a media interview with NuGen, please contact:

    Morna Gorman
    (416) 553-1732
    morna@nugenmd.com

    Notice Regarding Forward-Looking Information:

    Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release.

    This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.

    Seite 2 von 3


    Diskutieren Sie über die enthaltenen Werte


    newsfile
    0 Follower
    Autor folgen

    Verfasst von newsfile
    NuGen Receives Order for Repeat Demand in Mexico - Seite 2 Toronto, Ontario--(Newsfile Corp. - July 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that Science Link, …